These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8038611)

  • 1. Beryllium-induced disturbances of the murine immune system reflect some phenomena observed in sarcoidosis.
    Pfeifer S; Bartlett R; Strausz J; Haller S; Müller-Quernheim J
    Int Arch Allergy Immunol; 1994 Aug; 104(4):332-9. PubMed ID: 8038611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immune model of beryllium-induced pulmonary granulomata in mice. Histopathology, immune reactivity, and flow-cytometric analysis of bronchoalveolar lavage-derived cells.
    Huang H; Meyer KC; Kubai L; Auerbach R
    Lab Invest; 1992 Jul; 67(1):138-46. PubMed ID: 1625444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model of pulmonary granulomata induced by beryllium sulfate in the rat.
    Votto JJ; Barton RW; Gionfriddo MA; Cole SR; McCormick JR; Thrall RS
    Sarcoidosis; 1987 Mar; 4(1):71-6. PubMed ID: 2954196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogenic effect of beryllium sulfate on mouse B lymphocytes but not T lymphocytes in vitro.
    Newmann LS; Campbell PA
    Int Arch Allergy Appl Immunol; 1987; 84(3):223-7. PubMed ID: 3498695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic granulomatous pneumonia and lymphocytic responses induced by inhaled beryllium metal in A/J and C3H/HeJ mice.
    Nikula KJ; Swafford DS; Hoover MD; Tohulka MD; Finch GL
    Toxicol Pathol; 1997; 25(1):2-12. PubMed ID: 9061844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Limits of beryllium detection with laser microprobe mass spectrometry (LAMMS)].
    Entzian P; Pawelek W; Lindner B; Schlaak M; Zabel P; Müller-Quernheim J
    Pneumologie; 1998 Dec; 52(12):674-9. PubMed ID: 10028838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogenic effects of beryllium and zirconium salts on mouse splenocytes in vitro.
    Price RJ; Skilleter DN
    Toxicol Lett; 1986 Jan; 30(1):89-95. PubMed ID: 3485317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beryllium-stimulated in vitro migration of peripheral blood lymphocytes.
    Sawyer RT; Doherty DE; Schumacher BA; Newman LS
    Toxicology; 1999 Nov; 138(3):155-63. PubMed ID: 10593506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease.
    Sawyer RT; Day BJ; Fadok VA; Chiarappa-Zucca M; Maier LA; Fontenot AP; Silveira L; Newman LS
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):470-7. PubMed ID: 15256386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of differentially regulated mRNAs in monocytic cells induced by in vitro stimulation with Kveim-Siltzbach test reagent.
    Gaede KI; Kataria YP; Mamat U; Müller-Quernheim J
    Exp Lung Res; 2004; 30(3):181-92. PubMed ID: 15195552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beryllium induces IL-2 and IFN-gamma in berylliosis.
    Tinkle SS; Kittle LA; Schumacher BA; Newman LS
    J Immunol; 1997 Jan; 158(1):518-26. PubMed ID: 8977230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69.
    Amicosante M; Sanarico N; Berretta F; Arroyo J; Lombardi G; Lechler R; Colizzi V; Saltini C
    Hum Immunol; 2001 Jul; 62(7):686-93. PubMed ID: 11423174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is chronic beryllium disease sarcoidosis of known etiology?
    Rossman MD; Kreider ME
    Sarcoidosis Vasc Diffuse Lung Dis; 2003 Jun; 20(2):104-9. PubMed ID: 12870719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of proliferation tests to evaluate the effects of complexing agents on beryllium toxicity.
    Stephan CH; Sauvé S; Fournier M; Brousseau P
    J Appl Toxicol; 2009 Jan; 29(1):27-35. PubMed ID: 18785683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease.
    Tinkle SS; Kittle LA; Newman LS
    J Immunol; 1999 Sep; 163(5):2747-53. PubMed ID: 10453017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.
    Robinson BW; McLemore TL; Crystal RG
    J Clin Invest; 1985 May; 75(5):1488-95. PubMed ID: 3923038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogenic potential and genomic instability of beryllium sulphate in BALB/c-3T3 cells.
    Keshava N; Zhou G; Spruill M; Ensell M; Ong TM
    Mol Cell Biochem; 2001 Jun; 222(1-2):69-76. PubMed ID: 11678613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta.
    Bost TW; Riches DW; Schumacher B; Carré PC; Khan TZ; Martinez JA; Newman LS
    Am J Respir Cell Mol Biol; 1994 May; 10(5):506-13. PubMed ID: 8179912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium.
    Newman LS; Kreiss K
    Am Rev Respir Dis; 1992 May; 145(5):1212-4. PubMed ID: 1586067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis.
    Venet A; Hance AJ; Saltini C; Robinson BW; Crystal RG
    J Clin Invest; 1985 Jan; 75(1):293-301. PubMed ID: 3871200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.